Northland Capmk Brokers Boost Earnings Estimates for Enovix

Key Points

• Northland Capmk slightly raised its Q1 2026 EPS forecast for Enovix to ($0.23) from ($0.24) and projects FY2026 EPS of ($1.06), with Q2 at ($0.23) and Q4 at ($0.29).
• Analyst sentiment is mixed — the consensus rating is Hold with an average price target of $17.50, while individual targets and ratings range from Benchmark's $25 "buy" to Weiss Ratings' "sell" and JPMorgan's $10 neutral target.
• Enovix shares trade around $7.50 with a $1.62 billion market cap, negative earnings and margins, about 50.9% institutional ownership, and recent insider selling by the COO.

Enovix Corporation (NASDAQ:ENVX - Free Report) - Stock analysts at Northland Capmk boosted their Q1 2026 EPS estimates for shares of Enovix in a research report issued on Monday, November 17th. Northland Capmk analyst G. Richard now expects that the company will post earnings of ($0.23) per share for the quarter, up from their previous estimate of ($0.24). The consensus estimate for Enovix's current full-year earnings is ($1.01) per share. Northland Capmk also issued estimates for Enovix's Q2 2026 earnings at ($0.23) EPS, Q4 2026 earnings at ($0.29) EPS and FY2026 earnings at ($1.06) EPS.

A number of other analysts also recently weighed in on ENVX. Oppenheimer set a $24.00 price target on shares of Enovix in a research report on Thursday, November 6th. Benchmark increased their target price on shares of Enovix from $15.00 to $25.00 and gave the stock a "buy" rating in a report on Friday, July 25th. Weiss Ratings reissued a "sell (d-)" rating on shares of Enovix in a report on Friday, October 31st. JPMorgan Chase & Co. lowered their price objective on shares of Enovix from $12.00 to $10.00 and set a "neutral" rating for the company in a research report on Wednesday, November 12th. Finally, Wall Street Zen lowered Enovix from a "hold" rating to a "sell" rating in a report on Saturday, September 6th. Five analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $17.50.

Enovix Price Performance

Shares of ENVX opened at $7.50 on Wednesday. The stock has a market cap of $1.62 billion, a P/E ratio of -9.26 and a beta of 2.09. Enovix has a 1 year low of $5.27 and a 1 year high of $16.49. The stock's 50-day moving average price is $10.65 and its two-hundred day moving average price is $10.33. The company has a current ratio of 9.72, a quick ratio of 9.47 and a debt-to-equity ratio of 1.74.

Enovix (NASDAQ:ENVX - Get Free Report) last announced its quarterly earnings data on Tuesday, September 9th. The company reported ($0.13) EPS for the quarter. The company had revenue of $7.47 million for the quarter. Enovix had a negative return on equity of 61.78% and a negative net margin of 525.93%.

Institutional Trading of Enovix

Institutional investors have recently modified their holdings of the company. Caitlin John LLC acquired a new stake in Enovix in the 3rd quarter valued at approximately $27,000. Stone House Investment Management LLC bought a new position in shares of Enovix during the 1st quarter worth approximately $37,000. Parallel Advisors LLC raised its holdings in shares of Enovix by 51.9% in the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company's stock valued at $39,000 after purchasing an additional 1,342 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Enovix in the third quarter worth $80,000. Finally, Integrity Alliance LLC. acquired a new position in Enovix during the first quarter worth $98,000. 50.92% of the stock is currently owned by institutional investors.

Insider Activity at Enovix

In related news, COO Ajay Marathe sold 18,614 shares of the business's stock in a transaction on Wednesday, October 8th. The shares were sold at an average price of $13.00, for a total value of $241,982.00. Following the sale, the chief operating officer directly owned 1,002,684 shares of the company's stock, valued at approximately $13,034,892. The trade was a 1.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 14.10% of the stock is currently owned by insiders.

About Enovix

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.